Narrow search
Showing 1 - 10 of 4,012
Cover Image
Do optional deductibles reduce the number of doctor visits? : empirical evidence with German data
Schmitz, Hendrik - 2008
determine the price elasticity of demand for health care. A latent class approach that takes into account the panel structure of … increases the number of doctor visits. However, altogether the effects of the insurance state on the demand for doctor visits …
Persistent link: https://www.econbiz.de/10011633519
Cover Image
Do Optional Deductibles Reduce the Number of Doctor Visits? Empirical Evidence with German Data
Schmitz, Hendrik - 2008
determine the price elasticity of demand for health care. A latent class approach that takes into account the panel structure of … increases the number of doctor visits. However, altogether the effects of the insurance state on the demand for doctor visits …
Persistent link: https://www.econbiz.de/10014213324
Cover Image
Do optional deductibles reduce the number of doctor visits? : empirical evidence with German dat
Schmitz, Hendrik (contributor) - 2008
determine the price elasticity of demand for health care. A latent class approach that takes into account the panel structure of … increases the number of doctor visits. However, altogether the effects of the insurance state on the demand for doctor visits …
Persistent link: https://www.econbiz.de/10003785047
Cover Image
Copayments for doctor visits in Germany and the probability of visiting a physician : evidence from a natural experiment
Farbmacher, Helmut - 2009
The German health care reform of 2004 imposes a charge of 10 Euro for the first visit to a doctor in each quarter of the year. At first glance, there is no inhibiting effect of this fee on utilization in the German Socio-Economic Panel. However, this study reveals that the true effect is diluted...
Persistent link: https://www.econbiz.de/10003951754
Cover Image
The impact of physician preferences and patient habits on the diffusion of new drugs
Johannesson, Magnus (contributor);  … - 2001 - [Elektronische Ressource], First version: April, 2001, Rev. August 12, 2002
diuretics and beta-blockers. We use a prescription micro dataset where both patients and physicians can be followed over time …%). -- pharmaceuticals ; physician behavior ; habit formation ; mixed logit estimator …
Persistent link: https://www.econbiz.de/10001607831
Cover Image
Copayments for ambulatory care in Germany : a natural experiment using a difference-in-difference approach
Schreyögg, Jonas; Grabka, Markus M. - 2010
-in-difference approach to examine whether the new copayment effectively reduced the overall demand for physician visits and to explore … demand for physician visits. It is likely that this result is due to the design of the copayment scheme, as the copayment is …
Persistent link: https://www.econbiz.de/10009663837
Cover Image
Copayments for ambulatory care in Germany : a natural experiment using a difference-in-difference approach
Schreyögg, Jonas; Grabka, Markus M. - 2008
-in-difference approach to examine whether the new copayment effectively reduced the overall demand for physician visits and to explore … demand for physician visits. It is likely that this result is due to the design of the copayment scheme, as the copayment is …
Persistent link: https://www.econbiz.de/10011632066
Cover Image
Copayments for Ambulatory Care in Germany : A Natural Experiment Using a Difference-in-Difference Approach
Schreyoegg, Jonas; Grabka, Markus - 2010
-in-difference approach to examine whether the new copayment effectively reduced the overall demand for physician visits and to explore … demand for physician visits. It is likely that this result is due to the design of the copayment scheme, as the copayment is …
Persistent link: https://www.econbiz.de/10014218988
Cover Image
Copayments for Ambulatory Care in Germany : A Natural Experiment Using a Difference-in-Difference Approach
Schreyogg, Jonas; Grabka, Markus - 2008
-in-difference approach to examine whether the new copayment effectively reduced the overall demand for physician visits and to explore … demand for physician visits. It is likely that this result is due to the design of the copayment scheme, as the copayment is …
Persistent link: https://www.econbiz.de/10014218994
Cover Image
Can Branded Drugs Benefit from Generic Entry? Switching to Non-Bioequivalent Molecules and the Role of Physician Response to Detailing and Prices
Gonzalez, Jorge; Sismeiro, Catarina; Dutta, Shantanu; … - 2012
Patent expiration represents a turning point for the brand losing patent protection as bioequivalent generic versions of the drug quickly enter the market at reduced prices. In this paper, we study how physician characteristics and their prescribing decisions impact the competition among...
Persistent link: https://www.econbiz.de/10014025989